A Novel Self-Learning Framework for Bladder Cancer Grading Using Histopathological Images

[1]  Valery Naranjo,et al.  An Attention-based Weakly Supervised framework for Spitzoid Melanocytic Lesion Diagnosis in WSI , 2021, ArXiv.

[2]  Xuelei Ma,et al.  Application of deep learning as a noninvasive tool to differentiate muscle-invasive bladder cancer and non-muscle-invasive bladder cancer with CT. , 2021, European journal of radiology.

[3]  Adrián Colomer,et al.  Self-Learning for Weakly Supervised Gleason Grading of Local Patterns , 2021, IEEE Journal of Biomedical and Health Informatics.

[4]  Adrián Colomer,et al.  A deep embedded refined clustering approach for breast cancer distinction based on DNA methylation , 2021, Neural Computing and Applications.

[5]  D. D. de Bruin,et al.  Deep Learning-based Recurrence Prediction in Patients with Non-muscle-invasive Bladder Cancer. , 2020, European urology focus.

[6]  Shanshan Wang,et al.  Automatic recognition of bladder tumours using deep learning technology and its clinical application , 2020, The international journal of medical robotics + computer assisted surgery : MRCAS.

[7]  Rui Li,et al.  Histopathological distinction of non-invasive and invasive bladder cancers using machine learning approaches , 2020, BMC Medical Informatics and Decision Making.

[8]  Amos Storkey,et al.  Self-Supervised Relational Reasoning for Representation Learning , 2020, NeurIPS.

[9]  Michael Wand,et al.  Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides. , 2020, European urology.

[10]  P. Choyke,et al.  Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer. , 2020, JCO clinical cancer informatics.

[11]  Geoffrey E. Hinton,et al.  A Simple Framework for Contrastive Learning of Visual Representations , 2020, ICML.

[12]  H. Nishiyama,et al.  Support System of Cystoscopic Diagnosis for Bladder Cancer Based on Artificial Intelligence , 2019, Journal of endourology.

[13]  Koichi Tanno,et al.  A Deep Time-delay Embedded Algorithm for Unsupervised Stress Speech Clustering , 2019, 2019 IEEE International Conference on Systems, Man and Cybernetics (SMC).

[14]  Hai Su,et al.  Pathologist-level interpretable whole-slide cancer diagnosis with deep learning , 2019, Nat. Mach. Intell..

[15]  Nicolas Brieu,et al.  Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis , 2019, Scientific Reports.

[16]  S. Park,et al.  Deep transfer learning approach to predict tumor mutation burden (TMB) and delineate spatial heterogeneity of TMB within tumors from whole slide images , 2019, bioRxiv.

[17]  Trygve Eftestøl,et al.  Multiclass Tissue Classification of Whole-Slide Histological Images using Convolutional Neural Networks , 2019, ICPRAM.

[18]  Ali Gholipour,et al.  Semi-Supervised Learning With Deep Embedded Clustering for Image Classification and Segmentation , 2019, IEEE Access.

[19]  En Zhu,et al.  Deep Embedded Clustering with Data Augmentation , 2018, ACML.

[20]  Jing Yuan,et al.  Multiregion segmentation of bladder cancer structures in MRI with progressive dilated convolutional networks , 2018, Medical physics.

[21]  Nikos Komodakis,et al.  Unsupervised Representation Learning by Predicting Image Rotations , 2018, ICLR.

[22]  L. Lorenzo.  Valor pronóstico de la presencia de un componente tumoral indiferenciado ("tumor budding") en pacientes con carcinoma vesical músculo-invasivo , 2018 .

[23]  En Zhu,et al.  Deep Clustering with Convolutional Autoencoders , 2017, ICONIP.

[24]  Jacques Ferlay,et al.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.

[25]  E. Kikuchi,et al.  Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers , 2016, Cancer science.

[26]  Wei-Yun Yau,et al.  Deep Subspace Clustering with Sparsity Prior , 2016, IJCAI.

[27]  S. Hautaniemi,et al.  Prognostic value of tumour budding in oesophageal cancer: a meta‐analysis , 2016, Histopathology.

[28]  Bolei Zhou,et al.  Learning Deep Features for Discriminative Localization , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[29]  Ali Farhadi,et al.  Unsupervised Deep Embedding for Clustering Analysis , 2015, ICML.

[30]  Zhuo Chen,et al.  Deep clustering: Discriminative embeddings for segmentation and separation , 2015, 2016 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP).

[31]  Sergey Ioffe,et al.  Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift , 2015, ICML.

[32]  N. Smith,et al.  The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. , 2014, The Journal of urology.

[33]  I. Zlobec,et al.  Tumour budding is a strong and independent prognostic factor in pancreatic cancer. , 2013, European journal of cancer.

[34]  Matthew D. Zeiler.  ADADELTA: An Adaptive Learning Rate Method , 2012, ArXiv.

[35]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[36]  I. Zlobec,et al.  The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer , 2012, Histopathology.

[37]  H. Kijima,et al.  Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients , 2012, Molecular medicine reports.

[38]  Jürgen Schmidhuber,et al.  Stacked Convolutional Auto-Encoders for Hierarchical Feature Extraction , 2011, ICANN.

[39]  L. Terracciano,et al.  CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer , 2009, British Journal of Cancer.

[40]  Tsutomu Yoshida,et al.  Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths , 2009, Scandinavian journal of gastroenterology.

[41]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[42]  G. Feil,et al.  Pruebas de marcadores tumorales en el cáncer de vejiga , 2006 .

[43]  M. Barten,et al.  Tumour budding as prognostic factor in stage I/II colorectal carcinoma , 2005, Histopathology.

[44]  Christer Busch,et al.  The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems , 2002, Virchows Archiv.

[45]  D. Grignon,et al.  Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. , 2000, The American journal of surgical pathology.

[46]  D. Lamm.  Diagnosis and treatment of bladder cancer , 1992, Anti-cancer drugs.